Digestive System Neuroendocrine Carcinoma
generalAn aggressive high-grade carcinoma with neuroendocrine differentiation that arises from the digestive system. It is composed of malignant small or large cells. The mitotic count is more than 20 per 2 mm2 and/or the Ki-67 index is more than 20% (often more than 70%).
65
Centers
259
Active Trials
$18.0B
Cancer Funding
Specific Cancer Types(4)
Top Centers for Digestive System Neuroendocrine Carcinoma(65)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →